(Q35016759)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

5 August 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma (English)

1 reference

5 August 2017

1 reference

Sascha A Tuchman

8

0 references

author name string

Marvaretta Stevenson

1

1 reference

5 August 2017

William Mostertz

2

1 reference

5 August 2017

Chaitanya Acharya

3

1 reference

5 August 2017

William Kim

4

1 reference

5 August 2017

Kelli Walters

5

1 reference

5 August 2017

William Barry

6

1 reference

5 August 2017

Kristin Higgins

7

1 reference

5 August 2017

Jeffrey Crawford

9

1 reference

5 August 2017

Gordana Vlahovic

10

1 reference

5 August 2017

Neal Ready

11

1 reference

5 August 2017

Mark Onaitis

12

1 reference

5 August 2017

Anil Potti

13

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

5 August 2017

Clinical Cancer Research

1 reference

5 August 2017

15

1 reference

5 August 2017

24

1 reference

5 August 2017

7553-7561

1 reference

Genomic signatures to guide the use of chemotherapeutics.

5 August 2017

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1038/NM1491

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1200/JCO.2006.06.3743

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Molecular analysis-based treatment strategies for non-small cell lung cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Adjuvant chemotherapy for resected non-small cell lung cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

A five-gene signature and clinical outcome in non-small-cell lung cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Modeling cancer progression via pathway dependencies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Cancer statistics, 2008

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

"Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Cancer stem cells: a step toward the cure.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Cancer. A bull's eye for targeted lung cancer therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Linking oncogenic pathways with therapeutic opportunities

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Gene-expression profiles predict survival of patients with lung adenocarcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Predicting the clinical status of human breast cancer by using gene expression profiles

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

2 references

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1056/NEJMOA060467

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Pharmacogenomics: a reality or still a promise?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Module map of stem cell genes guides creation of epithelial cancer stem cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Utilization of genomic signatures to direct use of primary chemotherapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-09-1939

Identifiers

DOI

10.1158/1078-0432.CCR-09-1939

1 reference

5 August 2017

1 reference